Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis.

Johannes Roksund HovKirsten M BobergEli TaraldsrudMette VesterhusMaria BoyadzhievaInger Camilla SolbergErik SchrumpfMorten H VatnBenedicte A LieØyvind MolbergTom H Karlsen

Published in: Liver international : official journal of the International Association for the Study of the Liver (2016)

Antineutrophil cytoplasmic antibodies identified PSC patients with particular clinical and genetic characteristics, suggesting that ANCA may mark a clinically relevant pathogenetic subgroup in the PSC-UC disease spectrum.

Keyphrases

genome wide
copy number
randomized controlled trial
ulcerative colitis
phase iii
double blind